An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States Meeting Abstract


Authors: Oluwole, O.; Patel, A.; Vadgama, S.; Smith, N.; Blissett, R. S.; Feng, C.; Dickinson, M.; Johnston, P.; Perales, M. A.
Abstract Title: An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States
Meeting Title: ISPOR Europe 2023
Journal Title: Value in Health
Volume: 26
Issue: 12 Suppl.
Meeting Dates: 2023 Nov 12-15
Meeting Location: Copenhagen, Denmark
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2023-12-01
Start Page: S151
Language: English
ACCESSION: WOS:001137279501052
PROVIDER: wos
DOI: 10.1016/j.jval.2023.09.783
Notes: Meeting Abstract: EE518 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics